The Microfluidics market size is USD 27.3 Bn in 2026.
The Microfluidics market is projected to grow at a CAGR of 8% by 2033.
The Microfluidics market growth drivers include rising demand for point-of-care testing, increasing prevalence of chronic and infectious diseases, and growing adoption of microfluidics in diagnostics and research.
North America is a dominating region for Microfluidics market.
Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and Abbott Laboratories are some leading industry players in the Microfluidics market.